Clinical Trials Directory

Trials / Completed

CompletedNCT01965548

Treatment of Splenic Trauma: a Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
109 (actual)
Sponsor
University Hospital of North Norway · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In blunt trauma, the spleen is most frequent injured organ in the abdomen and the most frequent source of bleeding in the abdomen. Historically, splenectomy was the treatment of choice for splenic bleeding. For exsanguinating patients, open splenectomy is still the proper choice of treatment if the spleen is a significant source of bleeding. However, for hemodynamic stable patients with splenic injury, non-operative management (NOM) is an alternative, assuming they have no other indication for surgery (peritonitis). Non-operative management includes observation and/or splenic artery embolisation (SAE), but the indications for observation and SAE varies between trauma centers. The greatest advantage of NOM is the preservation of splenic function. In the investigators hospital splenic artery embolisation was introduced in 2007. The investigators want to describe the treatment of splenic injuries in their hospital, to see if the number of splenectomies has been recduced after 2007, and to see if SAE has also been used in transferred trauma patients.

Conditions

Interventions

TypeNameDescription
PROCEDURETreatment of splenic injuryThere are four possible treatments of splenic injury in this study: * splenectomy * splenic artery embolisation * non-operative management * any combination of the three treatments mentioned

Timeline

Start date
2014-09-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2013-10-18
Last updated
2016-01-11

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT01965548. Inclusion in this directory is not an endorsement.